Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X G Dou

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 10, 2024
[Strategies for hepatitis B virus-infected patients in the immune-tolerant phase: complete therapy at the last mile]Y Ding, Q J Sheng, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 10, 2025
[Progress in clinical research related to viral hepatitis in 2024]Y Ding, Y Li, B C Lu, et al.
Genetics and Molecular Research : GMR|December 16, 2014
Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapyL Zhang, C Q Hao, L Miao, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 16, 2019
[Re-recognition of occult hepatitis B virus infection]F M Lu, H Liao, Y Z Liu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 6, 2021
[Study on early predictive factors of an incomplete viral response with 48 week-entecavir therapy in HBeAg-positive chronic hepatitis B patients]Z F Zhou, Y Ding, C Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|April 7, 2024
[Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids]Q Q Jin, S S Liao, Y Qin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 3, 2023
[Clinical efficacy analysis of TMF for the treatment of hyperviremia HBeAg-positive chronic hepatitis B patients with incomplete response to first-line oral antiviral nucleos(t)ide analogues]Q J Sheng, C Han, Y W Li, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 15, 2018
[A case report of hepatitis B virus reactivation in both anti-HBs/-HBc positive patients with chronic lymphocytic leukemia after chemotherapy]Z R Yang, Q J Sheng, X Zhong, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 24, 2021
[Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury]Q J Sheng, Y Ding, C Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 7, 2017
[Consensus on pegylated interferon alpha in treatment of chronic hepatitis B]W H Zhang, D Z Zhang, X G Dou, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 10, 2024
[Strategies for hepatitis B virus-infected patients in the immune-tolerant phase: complete therapy at the last mile]Y Ding, Q J Sheng, X G Dou
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|February 10, 2025
[Progress in clinical research related to viral hepatitis in 2024]Y Ding, Y Li, B C Lu, et al.
Genetics and Molecular Research : GMR|December 16, 2014
Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapyL Zhang, C Q Hao, L Miao, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 16, 2019
[Re-recognition of occult hepatitis B virus infection]F M Lu, H Liao, Y Z Liu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 6, 2021
[Study on early predictive factors of an incomplete viral response with 48 week-entecavir therapy in HBeAg-positive chronic hepatitis B patients]Z F Zhou, Y Ding, C Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|April 7, 2024
[Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids]Q Q Jin, S S Liao, Y Qin, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 3, 2023
[Clinical efficacy analysis of TMF for the treatment of hyperviremia HBeAg-positive chronic hepatitis B patients with incomplete response to first-line oral antiviral nucleos(t)ide analogues]Q J Sheng, C Han, Y W Li, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|October 15, 2018
[A case report of hepatitis B virus reactivation in both anti-HBs/-HBc positive patients with chronic lymphocytic leukemia after chemotherapy]Z R Yang, Q J Sheng, X Zhong, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 24, 2021
[Analysis of clinical characteristics of patients with hyperthyroidism combined with liver injury]Q J Sheng, Y Ding, C Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|November 7, 2017
[Consensus on pegylated interferon alpha in treatment of chronic hepatitis B]W H Zhang, D Z Zhang, X G Dou, et al.
Pageof 4